Osteoarticular disorders affect approximately 10% of the world population and can be subdivided into inflammatory and degenerative forms. They are usually characterised by a chronic evolution that, when untreated, can result in irreversible damage to the joint structures leading to severe disability and impairment. Rheumatic diseases are painful conditions caused by joint or muscle inflammation, swelling and pain.
Due to aging, lesions and injuries, excess weight, inherited factors and abuse, on the one hand, and lack of exercise, on the other, the joints and related structures, such as the bones, ligaments and cartilage, can be affected by a series of degenerative disorders that have a negative influence on the activities of daily living. Osteoarthritis (OA) is the most common osteoarticular disorder and currently represents one of the main causes of disability worldwide. In Europe, OA causes moderate to severe disability in approximately 40 million people.
OA results in the wear of the protective cartilage, causing the exposed bones to rub together, which in turn produces a general deterioration in the joint, pain and stiffness after periods of inactivity or strenuous use. The joints most commonly affected are the knee, hip and the joints of the hand.
The IBSA osteoarticular portfolio includes various types of product for oral and intra-articular use.
Product: Sinovial one